Shortening treatment of tuberculosis: lessons from fluoroquinolone trials.
Division of Medicine, University College London, London, UK.
Camus
C
Nimmo
Division of Medicine, University College London, London, UK; Centre for Respiratory Medicine and Department of Medicine, Royal Free London NHS Foundation Trust, London, UK.
Marc
M
Lipman
Medical Research Council Clinical Trials Unit, University College London, London, UK.
Patrick P J
PP
Phillips
Division of Infection and Immunity, University College London, London, UK.
Timothy
T
McHugh
Medical Research Council Clinical Trials Unit, University College London, London, UK.
Andrew
A
Nunn
Medical Research Council Clinical Trials Unit, University College London, London, UK; Centre for Infectious Disease Epidemiology, Research Department of Infection and Population Health, University College London, London, UK. Electronic address: i.abubakar@ucl.ac.uk.
Ibrahim
I
Abubakar
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000379:methods; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D024841:Fluoroquinolones